Glioma has been considered to be the most frequent primary tumor within the central nervous system (CNS). The complexity of glioma, especially the existence of the blood-brain barrier (BBB), makes the survival and prognosis of glioma remain poor even after a standard treatment based on surgery, radiotherapy, and chemotherapy. This provides a rationale for the development of some novel therapeutic strategies. Among them, receptor-mediated drug delivery is a specific pattern taking advantage of differential expression of receptors between tumors and normal tissues. The strategy can actively transport drugs, such as small molecular drugs, gene medicines, and therapeutic proteins to glioma while minimizing adverse reactions. This review will summarize recent progress on receptor-mediated drug delivery systems targeting to glioma, and conclude the challenges and prospects of receptor-mediated glioma-targeted therapy for future applications.
from #Medicine via ola Kala on Inoreader http://ift.tt/1MCZRHb
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
2015
(2119)
-
▼
Δεκεμβρίου
(940)
-
▼
Δεκ 28
(53)
- Toxins, Vol. 8, Pages 5: Development of an Enzyme-...
- Influence of the Alcohol Present in a Phytotherapi...
- Energies, Vol. 9, Pages 18: Performance Characteri...
- Molecules, Vol. 21, Pages 8: The Synthesis of the ...
- Symmetry, Vol. 8, Pages 1: Structural Properties a...
- Molecules, Vol. 21, Pages 31: Terpenoids from the ...
- Sensors, Vol. 16, Pages 34: The Performance Analys...
- Buildings, Vol. 6, Pages 1: Acoustic Intervention ...
- Nutrients, Vol. 8, Pages 11: Clustering of Dietary...
- Religions, Vol. 7, Pages 4: “This Is Our Jerusalem...
- Sensors, Vol. 16, Pages 35: Effects of Operating P...
- Sustainability, Vol. 8, Pages 26: The Optimization...
- Nanomaterials, Vol. 6, Pages 3: Receptor-Mediated ...
- Humanities, Vol. 5, Pages 3: On Sound: Reconstruct...
- Toxins, Vol. 8, Pages 5: Development of an Enzyme-...
- Atmosphere, Vol. 7, Pages 3: Erratum: Hassan, M.; ...
- Systems, Vol. 4, Pages 2: A Research on Active Con...
- Nutrients, Vol. 8, Pages 16: Role of Chlorogenic A...
- IJMS, Vol. 17, Pages 37: The Role of bFGF in the E...
- IJMS, Vol. 17, Pages 33: Targeted Radionuclide The...
- IJMS, Vol. 17, Pages 25: Interleukin-10 Protection...
- Sustainability, Vol. 8, Pages 25: Using Social Med...
- IJMS, Vol. 17, Pages 33: Targeted Radionuclide The...
- Molecules, Vol. 21, Pages 26: Strong and Nonspecif...
- IJMS, Vol. 17, Pages 25: Interleukin-10 Protection...
- Molecules, Vol. 21, Pages 44: Site-Selective Ribos...
- IJMS, Vol. 17, Pages 37: The Role of bFGF in the E...
- BioEssays 1∕2016
- BioEssays 1∕2016
- BioEssays – Next Issue
- Pluripotency and the endogenous retrovirus HERVH: ...
- BioEssays 1∕2016
- Potentially Functional Polymorphisms in POU5F1 Gen...
- Exercise oxidative skeletal muscle metabolism in a...
- In The News: A roundup of news and information fro...
- Clinical and Translational Science (CTS): 2005–2015
- Arginase inhibition improves endothelial function ...
- High-dose cholecalciferol in critically ill patien...
- Prognostic indices in chronic lymphocytic leukaemi...
- Keck School researchers identify differences in co...
- Interaction between red meat intake and NAT2 genot...
- Expression and clinical implication of S100A12 in ...
- Food-specific response inhibition, dietary restrai...
- BAG3-mediated miRNA let-7g and let-7i inhibit prol...
- The Toronto Consensus statements for the managemen...
- FAM172A is a tumor suppressor in colorectal carcinoma
- Flavones induce immunomodulatory and anti-inflamma...
- Design of a dietary intervention to assess the imp...
- Capecitabine with/without mitomycin C: results of ...
- Combination of miR-125b and miR-27a enhances sensi...
- MicroRNA-122 confers sorafenib resistance to hepat...
- Genetic variants in IL-6/JAK/STAT3 pathway and the...
- Association between hepatitis B virus infection an...
-
▼
Δεκ 28
(53)
-
▼
Δεκεμβρίου
(940)
Αναζήτηση αυτού του ιστολογίου
Δευτέρα 28 Δεκεμβρίου 2015
Nanomaterials, Vol. 6, Pages 3: Receptor-Mediated Drug Delivery Systems Targeting to Glioma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.